Next Generation Approach

The increasing fear of drug-resistant superbugs is leading to a growing push for the next generation of antibiotics. The development of new antibiotics is crucial to controlling current and future infectious diseases caused by antibiotic-resistant bacteria. The discovery of a new antibiotic called teixobactin was announced by international team of researchers in 2017. The researchers now plan on studying the bacteria and decide what tools might be able to control its behavior to release its full antibiotic potential. An expected 5– 10% of all hospitalizations are perplex by a nosocomial disease with an expected cost of $4.5– 5.7 billion every year in the USA alone. More varieties of biological solution are yet to be discovered in this field.

 

  • Bacterial Biofilms
  • Oral Antibiotic Therapy
  • Combination Therapy
  • Empiric Antibiotic Therapy
  • Molecular Epidemiology

Related Conference of Next Generation Approach

August 24-24, 2022

3rd International Conference on Immunology & Immunotherapies

Singapore City, Singapore
September 16-16, 2022

4th World Conference on Vaccine and Immunology

Osaka, Japan
September 16-17, 2022

International Conference on Immunology Research

New York, USA
November 17-18, 2022

World Congress on Infectious and Contagious Disease

Berlin, Germany
February 20-21, 2023

Global Summit on SARS-CoV-2 virus

Madrid, Spain
February 21-22, 2023

4th European Congress on Hematology

Zurich, Switzerland
May 24-25, 2023

37th International Conference on Immunology

Vienna, Austria

Next Generation Approach Conference Speakers

Recommended Sessions

Related Journals

Are you interested in